Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress
8 months ago
By
In InvestmentsVenture Capital
aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence
9 months ago
By
In Biopharma HighlightsInnovationInvestmentsPeoplePharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast
9 months ago
By
In Biopharma HighlightsClinical TrialsInnovationInvestments
Outsized Funding in Early-Stage Biotech Points to Investor Confidence in Novel AI-Backed Oncology Tools
10 months ago
By
In AI & DataInvestments
Go to Inverstment